Over 100 HIV and LGBTQ+ groups sent President Biden a letter urging him to include the creation of a national grant program for the HIV prevention medication PrEP in his 2023 budget. Signatories of the letter — which include public health organizations, providers, community health centers, and more — contend that a national grant program would help to expand PrEP into marginalized communities that face significant disparities in PrEP access and uptake.
Proposed insurance rule ignites debate over transgender health care
Private insurance companies, patient advocacy groups and conservative organizations are at odds over a proposal to limit discrimination by health plans for medical care for transgender people and other LGBTQ consumers. The Biden administration, Democratic lawmakers and advocates say the proposal is essential for ensuring that LGBTQ people can access care, but some private insurers say the policy could drive up costs and the language describing what counts as discrimination is too vague. Meanwhile, conservative advocacy groups argue there is no clinical evidence for covering care that affirms the gender the consumer identifies with, such as hormone blockers or surgery.
HIV prevention, treatment: playing the long game
Drug manufacturers are developing long-acting, injectable HIV drugs for both treatment and prevention.
HIV stigma persists globally, according to Harris poll
“Here we are, 40 years in and we are still facing such ignorance, some stigma,” Carl Schmid, MBA, former co-chair of the Presidential Advisory Council on HIV/AIDS, and executive director of HIV+Policy Institute, told Medscape. “It’s gotten better, but it is really putting a damper on people being tested, getting treated, getting access to PrEP.”
Some HIV prevention clinics face major financial loss—but providers say Pittsburgh clinics are secure
Healthcare centers that provide the HIV-prevention medication PrEP in some states are facing financial peril after the maker of the drug slashed a crucial revenue stream. But centers in Pennsylvania and other Medicaid-expansion states will be less impacted by the change, Pittsburgh providers say. They expect to continue providing PrEP, a daily pill that prevents HIV with about 99% effectiveness, without disruption.